LIFETECH SCIENTIFIC CORPORATION

Ajouter à une liste

Communiqués LifeTech Scientific Corporation

Actions

1302

KYG548721177

Equipement et technologie médicale avancés

Marché Fermé - Hong Kong S.E. 10:08:05 05/10/2026			Varia. 5j.	Varia. 1 janv.
1,300 ^HKD	-0,76%		-0,38%	-16,67%

24/09	LifeTech Scientific Corporation obtient l’admission du système d’endoprothèse couverte à branche unique de la crosse aortique SureCham? à la procédure spéciale d’examen et d’approbation des dispositifs médicaux innovants	CI
24/09	Le système d’endoprothèse couvert de LifeTech Scientific intégré à la procédure spéciale d’examen des autorités chinoises	MT

Communiqués

31/03	LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%	PR
29/08/25	LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased	PR
31/03/25	LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%	AQ
28/03/25	LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%	PR
02/09/24	LifeTech Scientific Corporation Announced 2024 Interim Results: International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%	AQ
30/08/24	LifeTech Scientific Corporation Announced 2024 Interim Results: International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%	PR
02/04/24	LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development	PR
30/08/23	LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results	PR
29/03/23	LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022	PR
05/09/22	FDA-approved Investigator-initiated Pre-market Clinical Trial of LAmbre™ Plus LAA Closure System Obtained Medical Insurance Coverage in the US	PR
30/08/21	LifeTech Scientific : Announces 2021 Interim Results	AQ
20/04/21	LifeTech Scientific : List of Directors and their Roles and Functions	PU
16/04/21	LifeTech Scientific : (1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND (3) NOTICE OF ANNUAL GENERAL MEETING	PU
13/09/17	LifeTech Scientific : Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2017	PU
27/07/17	LifeTech Scientific : Poll Results of the Annual General Meeting Held on 25 July 2017	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Bourse
Actions
Action 1302
Actualités LifeTech Scientific Corporation
Communiqués

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !